Cannara Biotech Full Year 2024 Earnings: EPS: CA$0.071 (vs CA$0.078 in FY 2023)

Simply Wall St · 11/26 10:34

Cannara Biotech (CVE:LOVE) Full Year 2024 Results

Key Financial Results

  • Revenue: CA$82.1m (up 44% from FY 2023).
  • Net income: CA$6.44m (down 7.3% from FY 2023).
  • Profit margin: 7.8% (down from 12% in FY 2023).
  • EPS: CA$0.071 (down from CA$0.078 in FY 2023).
earnings-and-revenue-history
TSXV:LOVE Earnings and Revenue History November 26th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Cannara Biotech shares are up 32% from a week ago.

Risk Analysis

You should learn about the 5 warning signs we've spotted with Cannara Biotech (including 1 which is concerning).